Evidence map›Paper›PMID 40514755›Full record

ArticleExperimental hematology & oncology2025

Correction: Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma.

Cecilia Bandini, Elisabetta Mereu, Tina Paradzik, Maria Labrador, Monica Maccagno, Michela Cumerlato, Federico Oreglia, Lorenzo Prever, Veronica Manicardi, Elisa Taiana and 11 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental hematology & oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Cecilia BandiniDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Elisabetta MereuDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Tina ParadzikDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Maria LabradorDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Monica MaccagnoDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Michela CumerlatoDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Federico OregliaDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Lorenzo PreverDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Veronica ManicardiLaboratory of Translational Research, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy.
Elisa TaianaHematology, Fondazione Cà Granda IRCCS Policlinico, Milan, Italy.
Domenica RonchettiHematology, Fondazione Cà Granda IRCCS Policlinico, Milan, Italy.
Mattia D'AgostinoDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Francesca GayDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Alessandra LaroccaDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Lenka BesseExperimental Oncology and Hematology, Department of Oncology and Hematology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland.
Giorgio Roberto MerloDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Emilio HirschDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Alessia CiarrocchiLaboratory of Translational Research, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy.
Giorgio InghiramiDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Antonino NeriDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Roberto PivaDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy. roberto.piva@unito.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40514755
PMCPMC12164192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.